BOSTON SCIENTIFIC CORPBSX
時価総額
$1433.3億
PER
低侵襲医療向け医療機器の最大手で45年超の歴史。心血管・末梢・泌尿器向けのデバイスと低侵襲治療ソリューションを展開。2024年9月に同業を約11.3億ドルで、11月に約34.1億ドルで買収。127カ国で展開。
| 2010年 12月31日 | 2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | 2024年 12月31日 | |
| Cash and cash equivalents | 213 | 267 | 207 | 217 | 587 | 319 | 196 | 146 | 217 | 1,734 | 1,925 | 928 | 865 | 414 |
| Trade accounts receivable, net | 1,320 | 1,246 | - | - | - | - | - | - | - | 1,531 | 1,778 | 1,970 | 2,228 | 2,558 |
| Inventories | 894 | 931 | - | - | - | - | - | - | - | 1,351 | 1,610 | 1,867 | 2,484 | 2,810 |
| Prepaid Taxes | - | - | - | - | - | - | - | - | - | 194 | 205 | 264 | 315 | 307 |
| Other current assets | - | - | - | - | - | - | - | - | - | 751 | 799 | 731 | 621 | 831 |
| Total current assets | 3,615 | 3,105 | - | - | - | - | - | - | - | 6,694 | 6,317 | 5,760 | 6,514 | 6,920 |
| Property, plant and equipment, net | 1,697 | 1,670 | - | - | - | - | - | - | - | 2,084 | 2,252 | 2,446 | 2,859 | 3,294 |
| Goodwill | 10,186 | 9,761 | - | - | - | - | - | - | - | 9,951 | 11,988 | 12,920 | 14,387 | 17,089 |
| Other intangible assets, net | 6,343 | 6,473 | - | - | - | - | - | - | - | 5,917 | 6,121 | 5,902 | 6,003 | 6,684 |
| Deferred tax assets | - | - | - | - | - | - | - | - | - | 4,210 | 4,142 | 3,942 | 3,841 | 3,655 |
| Other long-term assets | 287 | 281 | - | - | - | - | - | - | - | 1,921 | 1,410 | 1,500 | 1,531 | 1,754 |
| TOTAL ASSETS | 22,128 | 21,290 | - | - | - | - | - | - | - | 30,777 | 32,229 | 32,469 | 35,136 | 39,395 |
| Debt, Current | 504 | 4 | - | - | - | - | - | - | - | 13 | 261 | 20 | 531 | 1,778 |
| Accounts payable | 184 | 203 | - | - | - | - | - | - | - | 513 | 794 | 862 | 942 | 960 |
| Accrued expenses | 1,626 | 1,327 | - | - | - | - | - | - | - | 2,197 | 2,436 | 2,160 | 2,646 | 2,773 |
| Other current liabilities | 295 | 273 | - | - | - | - | - | - | - | 958 | 783 | 761 | 814 | 887 |
| Total current liabilities | 2,609 | 1,807 | - | - | - | - | - | - | - | 3,681 | 4,274 | 3,803 | 4,933 | 6,399 |
| Long-term debt | 4,934 | 4,257 | - | - | - | - | - | - | - | 9,130 | 8,804 | 8,915 | 8,571 | 8,968 |
| Deferred tax liabilities | - | - | - | - | - | - | - | - | - | 330 | 310 | 144 | 134 | 155 |
| Other long-term liabilities | 1,645 | 2,008 | - | - | - | - | - | - | - | 2,309 | 2,220 | 2,035 | 1,967 | 1,870 |
| Preferred Stock, Value, Issued | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock, Value, Issued | 15 | 15 | - | - | - | - | - | - | - | 17 | 17 | 17 | 17 | 17 |
| Treasury stock, at cost - 263,289,848 shares as of December 31, 2024 and 2023 | - | 492 | - | - | - | - | - | - | - | 2,251 | 2,251 | 2,251 | 2,251 | 2,251 |
| Additional paid-in capital | 16,232 | 16,349 | - | - | - | - | - | - | - | 19,732 | 19,986 | 20,289 | 20,647 | 21,056 |
| Retained earnings | -4,822 | -4,381 | - | - | - | - | - | - | - | -2,378 | -1,392 | -750 | 819 | 2,673 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | - | - | - | - | - | - | - | - | - | - | - | 269 | 49 | 275 |
| Equity, Attributable to Parent | 11,296 | 11,353 | - | - | - | - | - | - | - | 15,326 | 16,622 | 17,573 | 19,530 | 22,003 |
| Noncontrolling interests | - | - | - | - | - | - | - | - | - | - | - | - | 248 | 233 |
| Total stockholders’ equity | 11,296 | 11,353 | - | - | - | - | - | - | - | 15,326 | 16,622 | 17,573 | 19,530 | 22,003 |
| TOTAL LIABILITIES AND EQUITY | 22,128 | 21,290 | - | - | - | - | - | - | - | 30,777 | 32,229 | 32,469 | 35,136 | 39,395 |